GeneGo ( states that Bristol-Myers Squibb ( licensed access to all of the company’s major products. Bristol-Myers Squibb can also access GeneGo tools to build its own canonical pathway maps using public, GeneGo, and proprietary data and have those maps included in statistical calculations and overlays. In addition, Bristol-Myers Squibb researchers can leverage GeneGo products to overlay their own internal interaction data in the context of manually curated pathways for more elucidation, according to the firms.